Document detail
ID
oai:pubmedcentral.nih.gov:1026...
Topic
Autophagic PunctumAuthor
Yin, Limin Zhou, Yu Liu, Hong Li, YangLangue
enEditor
Taylor & Francis
Category
Autophagy
Year
2022
listing date
11/28/2023
Keywords
disease study alzheimerAbstract
More than 55 million people are suffering from Alzheimer's disease (AD), but there is still no effective treatment for it.
Therefore, novel therapeutic approaches and regulatory mechanisms of protein quality control need to be further evaluated and dissected.
The lysosome is one of the major degradative organelles that maintain cellular homeostasis and protein quality control.
In our recent study, we have identified a group of LYsosome-Enhancing Compounds (LYECs), which significantly promote the activation of TFEB (transcription factor EB) and lysosome biogenesis via inhibiting dopamine transporters (DAT).
Injection of LH2-051, a member of the LYECs identified in this study, significantly improves learning, memory, and cognitive function of APP-PSEN1 mice, in which the enhanced capability of lysosomal degradation promotes the clearance of amyloid protein aggregates.
In summary, this study reports novel mechanisms of neurotransporter-mediated lysosome biogenesis and shows that DAT inhibition can alleviate the pathogenesis of Alzheimer's disease.
Yin, Limin,Zhou, Yu,Liu, Hong,Li, Yang, 2022, LYECs: lysosome-enhancing compounds as potential therapeutic approaches for Alzheimer disease, Taylor & Francis
TurkishMMLU: Measuring Massive Multitask Language Understanding in Turkish
evaluate provide turkishmmlu questions language
The Measurement of Acculturation in Neuropsychological Evaluations of Hispanic/Latino Individuals across the Lifespan: A Scoping Review of the Literature
evidence review lifespan various validation acculturation measures
